Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 191
Selected: 0
NCT IDTitle
NCT03182634The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial
NCT04151134Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning
NCT03262311Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours
NCT00028756Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
NCT07498829Population Based Germline Testing for Early Detection and Prevention of Cancer
NCT01332968A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
NCT073912155G-PEARL: Paxalisib in Malignant Brain Tumours
NCT02170415Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery
NCT02388308Evaluation of Clarity Ultrasound Guidance for Prostate Therapy
NCT00301925Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
NCT05782361POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
NCT00261456The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT02193633A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.
NCT00692354Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours
NCT03145961A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
NCT02437227Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833
NCT01476462Second Malignant Neoplasms After Childhood ALL Therapy
NCT02973828PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy
NCT00199901Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma
NCT00002892Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
NCT05082259ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
NCT02714621MR-HIFU for Recurrent Gynaecological Cancer
NCT03592550The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
NCT01460693Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia
NCT02998567Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
NCT01000129Adaptive Planning in Bladder Cancer
NCT04842799Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT03946202KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
NCT02126800Rapid Medical Donation Programme for Breast Cancer
NCT06126731Combination Study of Antibiotics With Enzalutamide (PROMIZE)
NCT00253409Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
NCT02541266Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation
NCT04763317Precision Medicine in the Prostate Cancer Care Pathway
NCT03727698Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment
NCT03506997Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer
NCT03466034The Role of Hypoxia as a Selective Pressure for TP53 Mutations
NCT02705846Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
NCT01395121A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread
NCT02757651KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response
NCT05741801Digital Alerts for Sepsis: a Qualitative Study
NCT01337401A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)
NCT06423976Microbiome Molecular Charaterisation
NCT00299286Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer
NCT00499174Observation or Radical Treatment in Patients With Prostate Cancer
NCT01024283Analysis of Pharmacodynamic Changes With AUY922A, an HSP90 Inhibitor
NCT00578240Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT04985266A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
NCT00005586Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
NCT01726374Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours
NCT011246823-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder